Finland· FI-REL-REL4889
Lonnoten
A minoxidil product, registered in Finland by Pharmacia & Upjohn Limited. The same ATC class is registered in 9 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Minoxidil is registered in 9 of 19 countries.
Countries holding a registration under ATC C02DC01 (minoxidil), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 3 of them publish a price we can compare per daily dose
Minoxidil · ATC C02DC01
9 / 19 countries
- Canada
- Denmark
- Finlandprice
- Germany
- Ireland
- Netherlands
- Norwayprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of minoxidil costs, country by country.
Normalised to the WHO defined daily dose (20 mg), so markets compare like for like.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Minoxidil · price per daily dose (20 mg)
USD · FX 28 Sept 2026
- FR France$0.70
- US United States$0.55 (acquisition cost)
- ES Spain$0.48
The record
At a glance
Fimea (Finland)- Manufacturer
- Pharmacia & Upjohn Limited
- Country
- Finland (FI)
- ATC code
- C02DC01
- ATC class
- Minoxidil
- Defined daily dose
- 20 mg, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
330 interactions on record for minoxidil.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Minoxidil · interactions on record
330 records
- 2 severe
- 187 moderate
- 2 minor
- 139 info
Most severe, free to view
- GuanethidineC02CC02severe
- TizanidineM03BX02severe
- DimenhydrinatA04AB02moderate
- ThiethylperazinA04AB03moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under C02DC01
Minoxidil, as other registers publish it.
- United States5%MinoxidilHairgrowthSprayGuangzhou Yixin Cross-border E-commerce Co., Ltd.
- United States5%MINOXIDILHAIRGROWTHSPRAYGuangzhou Yixin Cross-border E-commerce Co., Ltd.
- NorwayLonitenPharmacia & Upjohn Company LLC
- NorwayLonitenPharmacia & Upjohn Company LLC
- CanadaLONITEN 10MGPFIZER CANADA ULC
- United KingdomLoniten 10mg tabletsMawdsley-Brooks & Company Ltd
- United KingdomLoniten 10mg tabletsWaymade Healthcare Plc
- United KingdomLoniten 10mg tabletsPfizer Ltd
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e62239f5-5680-43e6-8822-fab93a0244de GET /v1/drugs/e62239f5-5680-43e6-8822-fab93a0244de?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "20",
"form": "tabletti",
"route": null,
"ddd_unit": "mg",
"strength": "10 mg",
"atc_label": "minoksidiili",
"ma_number": "8417",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL4889",
"authorised_at": "1982-12-01"
}See everything about minoxidil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.